-
3 spine, orthopedic devices earning FDA nods
Here are three spine and orthopedic devices that have earned FDA clearance that Becker's has reported on since Feb. 22: -
Orthofix realigns spine business, names bone growth therapies leader
Orthofix is realigning its spine business unit effective March 1, and the company named Jason Shallenberger as president of the bone growth therapies business. -
Spineart completes enrollment for cervical disc trial
Spineart completed enrollment for the U.S. investigational device exemption trial with the Baguera C cervical disc implant, the devicemaker said Feb. 29. -
Woven Orthopedics gets 2nd FDA clearance for Ogmend
Woven Orthopedics earned its second FDA 510(k) clearance for the Ogmed implantable sleeve, the company said Feb. 29. -
ZimVie's 2023 spine sales fall 9% ahead of sale
ZimVie posted spine sales decreases in the fourth quarter and full year ahead of its planned sale of the business segment. -
Nevro earns FDA clearance for SI joint fixation system
Nevro earned FDA 510(k) clearance to use its sacroiliac joint fixation system without having to include a lateral screw, the devicemaker said Feb. 28. -
4 medtech notes: Alphatec, Smith+Nephew and more
Here are four key developments from spine and orthopedic devicemakers since Feb. 21. -
Alphatec CEO aspires to building 'spine monster' on the heels of strong 2023
Alphatec CEO Pat Miles has big expectations for the company after a strong 2023. -
Smith+Nephew records $5.5B in 2023 revenue
Medtech company Smith+Nephew surpassed $5 billion in 2023 revenue, according to its Feb. 27 financial report. -
SI-Bone sees 'year of records' in 2023
Spine devicemaker SI-Bone saw $138.9 million in revenue in 2023, the company said Feb. 26. -
Aclarion announces $3M public offering
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26. -
4 patent lawsuits to know
In the last 11 months, several orthopedic and spine devicemakers have gone to court to defend their patents. -
10 spine device companies to watch in 2024
Spine devicemakers took important steps forward in innovation in 2023, and many are gearing up for exciting plans in the months ahead. -
Dr. Michael Gallizzi completes 1st Victory procedure
Michael Gallizzi, MD, completed the first procedure using Globus Medical's Victory lumbar plate system at Vail Valley Hospital Center in Vail, Colo., according to a Feb. 21 post on the devicemaker's Instagram profile. -
Man convicted of insider trading in $1.6B Mazor, Medtronic deal
Doron Tavlin, a former vice president of Mazor Robotics, was convicted by a federal jury for insider trading ahead of Mazor's acquisition by medical device company Medtronic. -
Globus Medical CEO's plan to remain No. 1 in spine
Globus Medical ended 2023 on a high note with full year sales of $1.6 billion, a 53.3% increase from 2022, and the company doesn't plan to take its foot off the gas. -
Centinel Spine's lumbar disc replacement implant earns new payer coverage
Centinel Spine earned coverage from a large commercial payer in Tennessee for one- and two-level lumbar disc replacement, the devicemaker said Feb. 21. -
Globus Medical sees revenues soar in 2023 after NuVasive merger
Globus Medical on Feb. 20 posted significant revenue growth for the fourth quarter and full year in 2023. -
Medtronic, Boston Scientific win spine patent battle against rival
An appeal board for the European Patent Office has revoked a pain management system patent belonging to California-based medical device company Nevro following a challenge from its competitors Medtronic and Boston Scientific, according to a Feb. 20 report from the Life Sciences Intellectual Property Review. -
First Neuralink patient makes 'full recovery': Elon Musk
The first person to receive a Neuralink implant has recovered and is operating a computer mouse using only their mind, CNN reported Feb. 20.
Page 14 of 201